WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that Bone Biologics Corporation (NASDAQ:BBLG), a developer of orthobiologic products for spine fusion, announced the pricing of an underwritten public offering of 3,777,778 units at an offering price of $1.35 per unit, for total gross proceeds of $5,100,000 before deducting underwriting discounts and commissions and other offering expenses.
JP Morgan Maintains Overweight on Micron Technology, Lowers Price Target to $80
JP Morgan analyst Harlan Sur maintains Micron Technology (NASDAQ:MU) with a Overweight and lowers the price target from $96 to $80.
